Earnings Summary

Century Therapeutics Inc’s revenue fell -92.91% since last year same period to $0.1Mn in the Q2 2023. On a quarterly growth basis, Century Therapeutics Inc has generated -94.24% fall in its revenue since last 3-months.

Century Therapeutics Inc’s net profit fell -7.43% since last year same period to $-33.29Mn in the Q2 2023. On a quarterly growth basis, Century Therapeutics Inc has generated -6.48% fall in its net profits since last 3-months.

Century Therapeutics Inc’s net profit margin fell -1414.9% since last year same period to -33627.27% in the Q2 2023. On a quarterly growth basis, Century Therapeutics Inc has generated -1750.02% fall in its net profit margins since last 3-months.

Century Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.54 - a -7.31% fall from last quarter’s estimates.

Century Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.54.

Century Therapeutics Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2023. This indicates that the Century Therapeutics Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.